Betacetylmethadol

Betacetylmethadol
Clinical data
ATC code	None;
Legal status
Legal status	AU: S9 (Prohibited substance); CA: Schedule I; DE: Anlage I (Authorized scientific use only); US: Schedule I;
Identifiers
	IUPAC name (3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanyl acetate;
CAS Number	17199-59-6;
PubChem CID	62710;
DrugBank	DB01522;
ChemSpider	56457;
ChEMBL	ChEMBL2105619;
CompTox Dashboard (EPA)	DTXSID30169199 ;
Chemical and physical data
Formula	C23H31NO2
Molar mass	353.498 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O[C@H](C(c1ccccc1)(c2ccccc2)C[C@H](N(C)C)C)CC)C;
	InChI InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22+/m1/s1; Key:XBMIVRRWGCYBTQ-GCJKJVERSA-N;

Betacetylmethadol is a synthetic opioid.^[1] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).^[1] In the United States, betacetylmethadol is a Schedule I drug Narcotic under the Controlled Substances Act, with an ACSCN of 9607 and a 2 gramme manufacturing quota as of 2014.^[2]

References

This analgesic-related article is a stub. You can help Wikipedia by expanding it.